full comment requir non-u analyst conflict disclosur
pleas click link
act like forgot day initi ceridian outperform
virtuou circl life
account matur inventori
acquisit corpor
mall dig deeper black friday promot
outlook soft side
posit takeaway ge healthcar checkup
switch strategi focu dinner set event-heavi
top question ahead manag meet
road manag
updat model prefer offer
price prior day market close estimate unless otherwis note
declin deceler wait decemb lap neg y/i growth
most-read note infrastructur
devop secur softwar
industri y/i
port halifax berth extens
 of daili summari
reflect timt
reflect timt
semiconductor reflect
timt confer
focu sub-sector highlight
find research
insight www rbcinsightresearch com global research destin web contact capit market sale
repres access global research site
feed cost rise littl impact commod price weak demand
theme confer
product crude natur ga higher
focu sub-seg monthli data
valu usd unless otherwis note
market data gbp financi data gbp dividend paid
act like forgot day initi ceridian outperform
initi coverag ceridian outperform rate price target
view ceridian disrupt innov leverag modern cloud tech
opportun chang fundament natur payrol mid-market larg
enterpris client acceler growth strong margin still low share
see long runway out-performance
initi coverag ceridian outperform rate price
see ceridian play larg hcm market number driver
catalyst next year like allow maintain high cloud
growth rate diminish drag legaci bureau busi
valu compani use sum-of-the-part approach cloud multipl
base similar payroll/hcm compani serv mid market
low multipl bureau busi
virtuou circl life
diageo grow revenu faster consum stapl compani
highli price higher margin categori bode well
ambit reliabl compound growth upgrad outperform
big believ virtuou circl school manag compani
invest drive revenu growth yield declin cost ratio enabl
rais margin step revenu invest diageo seem get
marketing/sal risen last three year look like
continu sale growth done likewis consum sentiment
largest brand amongst favour alcohol beverag sector
accord element data scienc team expect remain robust
model show revenu growth particularli good
highli price high margin categori tailwind categori mix
oper gear someth like margin growth per annum seem
realist result would oper profit growth upper end diageo
weve updat forecast currenc primarili sterl appreci
longer term forecast assum annual margin growth
previous also incorpor matur inventori cost
adjust present valu deriv valuat convers strength
valu eur unless otherwis note
diageo still result price target consequ rais
rate outperform
account matur inventori
increas price target reflect matur inventori
valuat previous captur rate remain sector
sell age liquid categori like cognac scotch provid formid
competit barrier new entrant deter cash outflow requir
lay matur inventori sever year start
earn distort balanc suppli demand favour incumb
produc view
come cost pernod ricard exampl forecast working-capit
outflow per annum order ensur suffici matur inventori
meet futur demand reason cash convers free cash flow/net
incom spirit compani like pernod ricard diageo tend low
standard consum stapl sector
reflect valu matur inventori adjust
present valu deriv price target conclud harsh given
matur inventori critic owner abil earn cash flow
futur even though gener immedi return consequ
ad matur inventori cost fair valu pernod ricard ad
price target rate remain sector perform
refer reader report diageo virtuou circl life
rais rate outperform partli result treat matur
inventori similar fashion
ctad present detail data ph iii emerge/
engag aducanumab alzheim studi thursday morn host
 session later afternoon
highlight key thing look present
clarifi whether aducanumab regulatori approv realist
overal would expect present break new ground given
likelihood alreadi provid compel data/analys
earn call
remain cautiou given uncertainti around aducanumab tefidera ip
sma competit
valu usd unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
acquisit corpor
take-away close compani announc acquir
corpor subsidiari nation instrument focus high-
frequenc rf eda softwar technolog softwar use microwav
rf engin design wireless product help acceler product
develop wide rang end-market aerospac
defens comput consum electron cadenc pay
cash add employe transact close
net net acquisit help compani expand posit rf
microwav design fit well compani virtuoso/spectr
platform clariti solver
what new market close monday sailpoint announc cam
mcmartin transit board director year-end mr mcmartin
current respons plan assum current manag
team move follow may manag chang saw mr mcmartin
transit cfo arriv jason ream new cfo
subsequ matt mill previous mapr technolog
appoint chief revenu offic septemb
view opportun catch manag follow
news dont believ indic execut issu rather time
mr mcmartin pull back day-to-day workload overal believ
compani better posit exit year good third quarter result
character improv execut overal posit tone follow
construct appear mid-novemb timt confer us
move signifi period transit cfo duti mr ream complet
mr mill fulli engag sale process new year
previous highlight expect mr mill add experi
scale busi sell senior execut migrat cloud
mr mcmartin miss overal remain posit sailpoint
long-term strateg outlook dont believ news
impact compani oper
despit unemploy multi-year low strong consum confid
softlin coverag character winner loser
categori leader defens name consist
see stronger trend mall-bas coverag lag layer
tariff concern specialti coverag trade discount histor
averag stock averag ytd vs
holiday season formal kick thanksgiv novemb vs
novemb last year short holiday season year day
time shift ad uncertainti retail outlook
shape holiday chang earlier promot pull demand forward
valu usd unless otherwis note
novemb note eight biggest in-stor shop day year still
ahead lot wood left chop holiday good news
base black friday store check promot analysi exhibit
see retail promot rel ration thu far
holiday season promot six ten specialti retail concept
anthropologi one better three line yoy
banana republ bath bodi work base mall-bas store
check ohio florida saw strong black friday result hollist
american eagl bath bodi work lululemon
model flat organ growth quarter vs con comp
though posit bia head print ep estim
in-line consensu expect gross margin expand quarter
base commod cost model built conjunct element
top line gross margin iri point top-lin growth
organ growth rbce con would still
bp deceler point last quarter
organ sale growth outperform iri bp impli organ growth
gross margin forecast model point slightli favor
cog environ juli quarter suggest slight tailwind y/i
poultri beef flour wheat egg aluminum oil natur ga inflationari
item includ veget corn chees soybean milk combin insight
element independ commod cost model peripher
readthrough believ gm estim reason
turn soup categori soup categori pressur
quit time dont agre consensu think
unfix manag acknowledg misstep past
year believ take appropri action via step
marketing/qu ingredi improv merchandis
innov also worth note soup despit struggl remain
import retail rank among top categori food store
report result market close expect upsid vs
consensu estim beyond result outlook believ investor
focus competition/potenti market consolid secur opportun
enterpris search elast cloud maintain outperform rate
price target remain bullish around opportun
valu usd unless otherwis note
valu usd unless otherwis note
need know expect anoth strong quarter outlook
report result sinc result
share vs like setup earn due
continu execut attract market opportun specif
consensu expect revenue/ep bill
reflect revenue/bil growth vs revenue/
bill growth bill see immedi bp tailwind
next year follow anniversari price chang cloud
offer consist recent market trip manag
believ investor look color around competit potenti
market consolid price endgam opportun around secur
enterpris search could growth catalyst view
opportun around cloud overal continu believ
well positionedto expand sizabl share applic site search
consolid spend observ grow earli share secur
maintain outperform rate price target remain
favorit devop coverag
outlook soft side
view guidanc metric given rel mute japan
sale expect remain weak margin impact invest
busi hear anyth call make us increment excit
anoth year stagnant top-lin bottom line result manag
specif said build year rather posit elsewher
better result construct
outlook call summari year invest implement
measur restart sale growth disappoint
guidanc us japanes channel area focu includ
strengthen distribut channel invest digit focus ramp
presenc area like dental vision
japan sale weak continu offer specif sale
forecast expect declin japan channel weigh overal
sale manag guid sale japan channel fall
model revis made small revis assumpt mostli
increas expens ratio reduc ep forecast
manag guid ep rang
assum yen exchang rate impli mostli flattish slightli
earn year adjust ep estim
factor conserv margin assumpt reduc ep
estim
report beat across board organ growth steadi mid
subscript revenu revenu beat smaller usual
organ beat fine bill beat usual adjust
estim reiter outperform rate
report strong strength across board
valu usd unless otherwis note
valu usd unless otherwis note
posit takeaway ge healthcar checkup
outperform-r ge host investor meet showcas healthcar
segment industri revenu ex-biopharma chicago
unveil new target low- mid-single-digit organ growth bp
digit precis new product vital target
certainli sound like core busi us
checkup showcas segment global senior leader ge
host healthcar investor day rsna confer chicago
senior leader across portfolio present busi
segment geograph trend opportun focu entir
bil healthcar remainco follow pend sale biopharma
like hear recur revenu account healthcar
mix well favor posit within bil address
market leverag on-going trend digital/ai solut demand
precis help tackl wast healthcar industri
improv accuraci diagnost said biggest unaddress question
long-term futur healthcar within portfolio recal
segment previous track ipo ceo larri replac
predecessor cancel separ replac sale
biopharma busi bil given spotlight throughout
investor day present cash invest made ge healthcar
roughli bil per year remainco certainli sound like core busi
us least medium term trim ep estim
reflect new disclosur healthcar segment outlook
